Categories AlphaGraphs, Earnings, Technology

NVDA Earnings: Nvidia Q1 profit beats estimates, revenues rise 46%

Nvidia Corporation (NASDAQ: NVDA) Wednesday said its first-quarter 2023 revenues and earnings increased, reflecting the strong demand for chips. The results also exceeded Wall Street’s prediction.

Nvidia Q1 2023 earnings infographic

The graphics chipmaker reported adjusted earnings of $1.36 per share for the April quarter, up from $0.91 per recorded a year earlier. Net income, including one-off items, dropped to $1.62 billion or $0.64 per share in the latest quarter from $1.91 billion or $0.76 per share in the first quarter of 2022.

Revenues grew 46% annually to $8.29 billion during the three-month period and came in above the estimates, reflecting strong performance by the gaming, data center, and professional visualization segments.

Check this space to read management/analysts’ comments on Nvidia’s Q1 earnings

The company’s stock closed Wednesday’s regular trading higher but declined during the extended session, following the announcement.

Prior Performance

  • Nvidia Q4 2022 earnings infographic
  • Nvidia Q2 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight